Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.341,27
0,57%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mereo BioPharma Group PLC (MREO) Mereo BioPharma Group PLC (MREO) Notizie

Mereo BioPharma Group PLC

MREO
3,72
0,04 (1,09%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202421:30EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202413:30GLOBEMereo BioPharma to Participate in Fireside Chat at the..
12/11/202413:30GLOBEMereo BioPharma Reports Third Quarter 2024 Financial Results..
17/9/202402:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202402:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202423:35GLOBEMereo BioPharma to Participate in Fireside Chat at the 2024..
12/9/202422:05EDGAR2Form 144 - Report of proposed sale of securities
12/9/202422:05EDGAR2Form 144 - Report of proposed sale of securities
13/8/202414:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202414:09EDGAR2Form 8-K - Current report
13/8/202414:00GLOBEMereo BioPharma Reports Second Quarter 2024 Financial..
17/6/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:30EDGAR2Form 8-K - Current report
14/6/202422:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/6/202413:50GLOBEMereo BioPharma Announces Pricing of $50 Million..
11/6/202423:47GLOBEUltragenyx and Mereo BioPharma Announce New Phase 2 Data..
11/6/202422:18EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
30/5/202413:30GLOBEMereo BioPharma to Participate in Fireside Chat at the..
24/5/202403:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202400:38EDGAR2Form 144 - Report of proposed sale of securities
23/5/202422:16EDGAR2Form 8-K - Current report
15/5/202422:49EDGAR2Form S-3 - Registration statement under Securities Act of..
15/5/202422:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202422:06EDGAR2Form 8-K - Current report
15/5/202422:01GLOBEMereo BioPharma Reports First Quarter 2024 Financial Results..
03/4/202413:30GLOBEMereo BioPharma to Participate in Fireside Chat at the 23rd..
27/3/202421:01GLOBEMereo BioPharma Reports Full Year 2023 Financial Results and..
05/3/202413:30GLOBEMereo BioPharma to Participate in Fireside Chat at the..
09/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202413:08EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEMereo BioPharma Provides Update on Pipeline Progress and..
02/1/202422:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202422:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202422:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202422:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202422:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202422:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/12/202322:16EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
18/12/202322:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202322:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 3,70 Min: 3,645 Max: 3,81
Chiusura: 3,68

La tua Cronologia

NASDAQ
MREO
Mereo BioPharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network